Spoken Alpha
Lumexa Imaging Holdings, Inc.
I cannot provide the requested description because the document excerpt provided does not contain Item 1 — Business. The text shown begins with Item 14 (Principal Accounting Fees and Services) and continues through exhibits, signatures, and other filing sections. To complete this task, I would need the actual Item 1 — Business section from the 10-K filing.
Lumexa Imaging Holdings, Inc is a Healthcare company operating in Medical Devices with a $1.10B market cap.
LMRI beat consensus EPS by 1.0% in Q2 FY2026, reported Aug 11, 2026.
3 earnings calls indexed on Spoken Alpha.
Behavioral analysis
Disclosures
Transcripts
Most recent calls indexed for this ticker. Open any call to drill into prepared remarks and Q&A.
History
Executives who appear on this company's earnings calls in our corpus, with role and tenure sourced from SEC filings. Click any name for the full role timeline and call appearance history. Per-executive behavioral deviation metrics are available to research subscribers.
Peers
Sector peers tracked by Spoken Alpha. Each links to the same machine-readable IR surface — earnings calls, executives, and accountability scores.
API
The same data on this page is available as a machine-readable feed via the Spoken Alpha API. One call returns the IR URL, recent transcripts, and accountability scores for LMRI.
$ curl https://api.spokenalpha.com/v1/companies/LMRIFAQ
Spoken Alpha indexes LMRI's earnings call transcripts at https://spokenalpha.com/companies/LMRI. Each call links to attributed speakers and parsed analyst Q&A.
Lumexa Imaging Holdings, Inc. (LMRI) held its most recent earnings call on 2026-08-12, covering fiscal Q2 2026.
Lumexa Imaging Holdings, Inc. (LMRI) operates in the Healthcare sector (Medical Devices industry).
| Period | Reported | EPS actual | EPS consensus | EPS surprise | Revenue actual | Revenue consensus | Rev. surprise | Source |
|---|---|---|---|---|---|---|---|---|
| Q2 FY2026 | 2026-08-11 | $0.10 | $0.03 | +100.0% | $264.2M | — | — | EODHD |
| Q1 FY2026 | 2026-05-12 | $0.02 | $0.12 | -85.4% | $252.5M | — | — | EODHD |
| Q4 FY2025 | 2026-03-25 | $0.01 | $0.05 | -80.0% | $267.7M | — | — | EODHD |
| Q3 FY2025 | 2025-12-02 | $-0.03 | $0.00 | — | $258.9M | — | — | EODHD |
Source: EODHD. LMRI reported actuals as published; sparse fields render as —.